Brofaromine versus imipramine in in-patients with major depression - A controlled trial

Journal of Affective Disorders

Volumn 44, Issue 2-3, 1997, Pages 91-99

  Volz, Hans Peter ^a   Gleiter, Cristoph H ^b   Möller, Hans Jürgen ^c  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Brofaromine; Controlled clinical trial; Imipramine; In patients; Major depression; Monoamine oxidase inhibitors; RIMA

Indexed keywords

BROFAROMINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; AGITATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIRIUM TREMENS; DEPRESSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HALITOSIS; HUMAN; HYPERHIDROSIS; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; SLEEP DISORDER; SYNCOPE; TACHYCARDIA; URINE RETENTION;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HOSPITALIZATION; HUMANS; IMIPRAMINE; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; PIPERIDINES; SLEEP DISORDERS;

EID: 0030799680     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(97)00031-1     Document Type: Article

References (29)

1. Abraham, H.C., Kanto, V.B., Rosen, J. and Standen J.L. (1963) A controlled clinical trial of imipramine (Tofranil) with outpatients. Br. J. Psychiatry 109, 286-293.
2. British Medical Research Council (1965) Clinical trial of the treatment of depressive illness. Br. Med. J. 1, 881-886.
3. Chouinard, G., Saxena, B.M., Nair, N.P.V., Kutcher, S.P., Bakish, D., Bradwejn, J., Kennedy, S.H., Sharma, V., Remick, R.A., Kukha-Hohamad, S.A., Beauclair, L., Snaith, J., Pohlman, H. and DeSouza, J. (1993) A Canadian multicenter placebo-controlled study of a fixed dose of brofaromine, a reversible and selective MAO-A inhibitor, in the treatment of depression. J. Affect. Disord. 32, 105-114.
4. Daneman, E.A. (1961) Imipramine in office management of depressive reactions (a double blind clinical study). Dis. Nerv. Syst. 22, 213-217.
5. Danish University Study Group (1993) Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. J. Affect. Disord. 28, 105-116.
6. Diagnostic and Statistical Manual of Mental Disorders (1984) American Psychiatric Association. 3rd. edition. Beltz, Weinheim and Basle.
7. Doucet, P., Tétrault, L., Bordeleau, J.M. and Blanchet, A. (1966) Evaluation comparative des propriétés antidépressives de l'Opipramol, de l'Imipramine et du placebo dans la dépression neurotique. Excerpta Medica, Amsterdam, 169-170, 4th World Congress of Psychiatry, Madrid.
8. Guelfi, J.D., Payan, C., Fermanian, J., Pedarriosse, A.-M. and Manfredi, R. (1992) Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clincal trial. Br. J. Psychiatry 160, 519-524.
9. Greenblatt, M., Grosser, G.M. and Wechsler, H. (1964) Differential response of hospitalized depressed patients to somatic therapy. Am. J. Psychiatry 120, 935-943.
10. Hamilton, M. (1960) A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56-62.
11. Helmchen, H. (1990) Ethical problems and designs of controlled clinical trials. In: Benkert, O., Maier, W., Rickels, K. (Eds.) Methodology of the Evaluation of Psychotropic Drugs. Springer, Berlin, pp. 82-90.
12. Klein, D.F., and Davis, J.M. (1969) Diagnosis and Drug Treatment of Psychiatric Disorders. William and Wilkins, Baltimore, MD.
13. Linden, M. (1987) Phase-IV-Forschung: Antidepressiva in der Nervenarztpraxis. Springer, Heidelberg.
14. Möller, H.-J. and Volz, H.-P. (1992) Brofaromine in major depressed patients I. A controlled clinical trial versus imipramine II. Open follow-up up to one year. J. Affect. Disord. 26, 163-172.
15. Möller, H.-J. and Volz, H.-P. (1993) Brofaromine in elderly depressed patients - a comparative trial versus imipramine. Europ. Neuropsychopharmacol. 3, 501-510.
16. Morris, J.B. and Beck, A.T. (1974) The efficacy of antidepressant drugs: a review of research (1958-1972). Arch. Gen. Psychiatry 30, 667-674.
17. Nair, N.P.V., Amin, M., Holm, P., Katona, C., Klitgaard, N., Ng Ying Kin, N.M.K., Kragh-Sørensen, P., Kühn, H., Leek, C.A., Stage, K.B. (1995) Moclobemide and nortriptyline in elderly depressed patients. A randomized, multicentre trial against placebo. J. Affect. Disord. 33, 1-9.
18. Neki, J.S. (1965) A comparative study of Tofranil, Niamid and Nardelzine in depressive states. Indian J. Psychiatry 7, 50-55.
19. Paykel, E.S. (1990) Placebo-controlled studies in depression: Necessity and feasibility. In: Benkert, O., Maier, W., Rickels, K. (Eds.) Methodology of the Evaluation of Psychotropic Drugs. Springer, Berlin, pp. 73-81.
20. Paykel, E.S. and White, J.L. (1989): A European study of views on the use of monoamine oxidase inhibitors. Br. J. Psychiatry 155 (suppl. 6), 9-17.
21. Rabkin, J.G., Quitkin, F.M., Patrick, G., Harrison, W and Tricamo, E. (1985) Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management. J. Clin. Psychopharmacol. 5, 2-9.
22. Raskin, A., Schulterbrandt, J.G., Raetig, N., Crook, T.H. and Odle, D. (1974) Depression subtypes and response to phenelzine, diazepam and a placebo. Results of a nine hospital collaborative study. Arch. Gen. Psychiatry 30, 66-75.
23. Schiwy, W., Heath, W.R. and Delini-Stula, A. (1989) Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients. J. Neural. Transm. 28 (Suppl.), 34-44.
24. Volz, H.-P., Heimann, H., Bellaire, J. and Möller, H.-J. (1993) Brofaromine in non-endogenous major depressed inpatients - results of a preliminary dose-finding trial versus tranylcypromine. Pharmacopsychiatry. 27, 152-158.
25. Volz, H.-P., Faltus, F., Magyar, I. and Möller, H.-J. (1994) Brofaromine in treatment-resistant major depressed patients - a comparative trial versus tranylcypromine. J. Affect. Disord. 30, 209-217.
26. Volz, H.-P., Gleiter, C.H., Struck, M. and Möller, H.-J. (1995) Brofaromine. Insight into the nature of drug development. CNS Drugs 3, 1-8.
27. Volz, H.-P., Gleiter C.H., Waldmeier, P.C., Struck, M. and Möller, H.-J. (1996) Brofaromine - a review of its pharmacological and therapeutic use. J. Neural. Transm. 103, 217-245.
28. West, E.D. and Dally, L.J. (1959) Effects of iproniazid in depressive syndromes. Br. Med. J. 1, 1491-1494.
29. von Zerssen, D. (1986) Clinical self-rating scales (CSRS) of the Munich psychiatric information system (Psychis München). In: Sartorius, N.T.A. Ban (Eds.), Assessment of Depression. Springer, Berlin, pp. 270-303.